If you or a loved one has been diagnosed with liver cancer, you know that the treatment options can be limited. But there is hope on the horizon in the form of y-92 radioembolization. This new minimally invasive procedure uses targeted radiation to kill cancer cells, and it is showing promise as a potential treatment option for patients with liver cancer. In this blog post, we will introduce y-92 radioembolization and discuss how it works, its potential benefits, and what the current research says about this promising new treatment.
What is Radioembolization?
Radioembolization, also known as Y-90 radioembolization, is a minimally invasive procedure that delivers high-dose radiation directly to liver tumors. This treatment is typically used for patients with inoperable liver cancer or those who have already undergone surgery or other treatments without success.
During the procedure, a small catheter is inserted into an artery in the groin and threaded through the blood vessels to the liver. Once in place, the catheter delivers radioactive microspheres (tiny beads) directly to the tumor(s). The microspheres lodge in the small blood vessels around the tumor and release their radiation over some time, destroying the cancer cells while sparing healthy tissue.
Radioembolization is usually performed on an outpatient basis and takes about two hours. Most patients experience minimal side effects from the procedure, and many can return to their normal activities within a few days.
If you are facing a diagnosis of liver cancer, talk to your doctor about whether radioembolization may be right for you.
How does Y-92 Radioembolization Work?
Radioembolization is a minimally invasive treatment option for patients with liver cancer. Y-radioembolization specifically uses yttrium-90 (Y-90) microspheres to deliver radiation directly to the tumor site.
The Y-90 microspheres are approximately the size of a red blood cell and are injected into the hepatic artery, which supplies blood to the liver. The microspheres become lodged in the small vessels around the tumor. Once in place, the Y-90 microspheres emit beta particles that destroy cancer cells by damaging their DNA.
Radioembolization is typically performed as an outpatient procedure and does not require hospitalization. Patients may experience some side effects from the treatment, such as fatigue, nausea, and pain at the injection site, but these are typically mild and resolve on their own within a few days.
Radioembolization is a safe and effective treatment option for patients with liver cancer who are not candidates for surgery or other traditional treatments. For more information about Y-radioembolization, please speak with your doctor or contact us at Liver Cancer Institute.
What are the Benefits of Y-92 Radioembolization?
Y- y-radioembolization, also called Yttrium-90 microsphere therapy, is a type of treatment for liver cancer that involves injecting radioactive microspheres into the liver. The microspheres target the cancerous cells and kill them with radiation. Y- radioembolization is a minimally invasive procedure that is done in an outpatient setting.
The benefits of Y- y-radioembolization include:
1. It is a minimally invasive procedure that can be done on an outpatient basis
2. It has minimal side effects
3. It is effective at treating liver cancer
4. It can be used to treat patients who are not candidates for surgery
5. It can be used in conjunction with other treatments, such as chemotherapy
Who is a Candidate for Y-92 Radioembolization?
Y-radioembolization is a new, minimally invasive treatment option for liver cancer patients that are showing great promise. This cutting-edge treatment uses Yttrium-90, a radioactive isotope, to target and destroy cancer cells while sparing healthy tissue.
Y-radioembolization is an ideal treatment option for patients with liver cancer who have not responded to other treatments, such as surgery, chemotherapy, or radiation therapy. The procedure is also considered safe and effective for patients who are not candidates for surgery or who are not able to tolerate traditional treatments.
If you or a loved one has been diagnosed with liver cancer, talk to your doctor about whether Y-radioembolization may be right for you.
What are the Risks and Side Effects of Y-92 Radioembolization?
Liver cancer is a serious and potentially fatal disease. While there are several treatment options available, each comes with its risks and side effects. Y- radioembolization is a new treatment option that is showing promise for treating liver cancer. However, as with any new treatment, there are risks and side effects associated with this therapy.
The most common side effect of Y- y-radioembolization is pain at the injection site. This pain is typically mild and goes away on its own within a few days. Other possible side effects include nausea, vomiting, diarrhea, fatigue, and flu-like symptoms. These side effects are usually temporary and resolve on their own within a week or two.
There are also some potential risks associated with Y- y-radioembolization. These include damage to nearby healthy tissue, bleeding, infection, and reactions to the contrast dye used during the procedure. Most of these risks are rare and can be effectively managed by your healthcare team.
If you are considering Y- y-radioembolization for the treatment of your liver cancer, it is important to discuss the risks and side effects with your doctor so that you can make an informed decision about whether this therapy is right for you.
How to Prepare for Y-92 Radioembolization?
Y-92 radioembolization is a new, minimally invasive treatment option for patients with liver cancer. The procedure uses Yttrium-90, a highly radioactive isotope, to target and destroy cancer cells.
To prepare for Y-92 radioembolization, patients must first undergo a CT scan or MRI to create a 3D image of the liver. This image is used to plan the placement of the radioactive beads. Patients will also meet with a radiation oncologist to discuss the risks and benefits of the procedure.
Before the procedure, patients will be asked to fast for 6 hours and drink only clear liquids. They will also be given a sedative to help them relax during the procedure.
The actual procedure takes about an hour. During this time, the radiation oncologist will insert a catheter into an artery in the groin and thread it up to the liver. The Y-92 beads are then injected through the catheter and into the arteries that supply blood to the tumor. Once in place, the beads give off radiation that destroys cancer cells while sparing healthy tissue.
After the procedure, patients will be monitored for any side effects. Most side effects are mild and resolve on their own within a few days or weeks. However, some patients may experience more severe side effects, such as nausea, vomiting, diarrhea, or fatigue. These side effects can usually be managed with medication.
Y-92 radioembolization is a new treatment option that is showing great promise for patients with liver cancer. This minimally invasive procedure uses targeted radiation to kill cancer cells and has few side effects. Y-92 radioembolization is currently only available at select hospitals, but we hope that this new treatment will become more widely available in the future so that more patients can benefit from it.